-
cds.ahrq.gov/cdsconnect/artifact/recommendation-8-naloxone-consideration
September 27, 2018 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdf
January 01, 2024 - As part of the Patient Population Under Consideration section of the full recommendation
statement, … Inclusions (from
the Patient
Population
Under
Consideration
section)
“Race = African
American … Inclusions
(from the Patient
Population
Under
Consideration
section)
“Ethnicity =
Hispanic … Although the racial/ethnic groups identified in the
Patient Population Under Consideration section of … Add explanation “No symptoms of
diabetes”
The Patient Population Under Consideration section of the
-
cds.ahrq.gov/sites/default/files/cds/artifact/686/Clostridium%20difficile%20(C.diff)%20Infection%20Treatment%20Pathway_updated%20March%202019.pdf
January 01, 1970 - fulminant CDI
NO,
First CDI Episode
YES,
Recurrent CDI Episode
Consult infectious disease (ID)
for consideration
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
January 01, 2024 - Depending on the availability and comprehensiveness of patient data sources, consideration of
other … As part of the Patient Population Under Consideration section of the full recommendation
statement, … Inclusions (from
the Patient
Population
Under
Consideration
section)
“Race = African
American … Inclusions (from
the Patient
Population
Under
Consideration
section)
“Race =
American Indian … Inclusions (from
the Patient
Population
Under
Consideration
section)
“Ethnicity =
Hispanic or
-
cds.ahrq.gov/sites/default/files/workgroups/246/jul-2017-cholesterol-wg-notes.docx
January 01, 2017 - Given the testing timeline, the implementation team decided to include this consideration in the recommendation … Clinical Domains
CAMH requested the WG’s feedback and experiences with numerous clinical domains under consideration … CDS warnings about high risk meds is a consideration.
-
cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
January 01, 2017 - Discuss Remaining Repository Questions
CAMH provided a brief overview of the metadata under current consideration
-
cds.ahrq.gov/sites/default/files/workgroups/211/dec-2016-cholesterol-wg-notes.docx
January 01, 2016 - validate identified artifacts for potential CDS build out, and identify additional clinical resources for consideration … Sources TBD
· Rules generated from CPGs
· ASCVD – Yes/No
· Determine 4 high risk groups for LLT consideration
-
cds.ahrq.gov/sites/default/files/workgroups/226/mar-2017-cholesterol-wg-notes.docx
January 01, 2017 - other than cirrhosis, e.g. fatty liver disease, shouldn’t be automatically excluded from statin therapy consideration
-
cds.ahrq.gov/sites/default/files/workgroups/241/jun-2017-cholesterol-wg-notes.docx
January 01, 2017 - Steps and Closing
CAMH will provide an update on the pilot and discuss clinical domain areas under consideration
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository_0.pdf
July 23, 2024 - hospice care)
▪ Undergoing active cancer treatment
since they have unique needs that require special consideration
-
cds.ahrq.gov/sites/default/files/workgroups/251/aug-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
08/09/2017
Time
1:30 – 2:45 PM EST
AGENDA
· Welcome and Review of Agenda
· Demonstration of the CDS Connect Repository
· Demonstration of the CDS Connect Authoring Tool
· Next Steps and Close
SUMMARY
Welcome
CAMH welcomed the attendees to the August…
-
cds.ahrq.gov/sites/default/files/workgroups/71451/CDS_Connect_WG_March_2022_Presentation.pdf
January 01, 2022 - March 2022 CDS Connect Work Group Presentation
March 2022 CDS Connect Work Group Call
Agenda
Schedule Topic
3:00 - 3:02 Roll Call, Michelle Lenox (MITRE)
3:02 - 3:05 Review of the Agenda, Maria Michaels (CDC)
3:05 - 3:50 CDS Artifact Versioning (MITRE/CDC/Alphora)
3:50 - 3:55 What's New with CDS Connect (MITR…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
January 01, 2023 - recommended preventive services based on that patient’s
individual health history and risk factors.7 Consideration … Depending on the availability and comprehensiveness of patient data sources, consideration of
other … patient preferences and effective patient decision making, facilitating
patient action, and ensuring consideration
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_CDS_Connect_IG_Healthy_Diet_Physical_Activity.pdf
January 01, 2024 - recommended preventive services based on that patient’s
individual health history and risk factors.3 Consideration … Depending on the availability and comprehensiveness of patient data sources, consideration of
other … With Cardiovascular Risk Factors: Behavioral
Counseling Interventions.2 The Patient Population Under Consideration … been shown to produce software that is more robust and to contain fewer bugs because it requires
consideration … interventions to promote a healthy diet and physical activity.”2 Within the Patient Population Under
Consideration
-
cds.ahrq.gov/sites/default/files/workgroups/71451/CDS_Connect_WG_March_2022_Summary.pdf
January 01, 2022 - March 2022 CDS Connect Work Group Summary
Clinical Decision Support (CDS) Connect Work Group (WG)
Meeting Summary
March 17, 2022
3:00 – 4:00 pm ET
Attendees: 37 people, including 4 phone dial-ins
Organization Attendees
AHRQ Sponsors Mario Teran; Roland Gamache; Steve Bernstein (3)
WG Members Andrey…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
January 01, 2024 - recommended preventive services based on that patient’s
individual health history and risk factors.7 Consideration … Depending on the availability and comprehensiveness of patient data sources, consideration of
other
-
cds.ahrq.gov/sites/default/files/workgroups/34806/CDS_Connect_WG_October_2021_Summary.pdf
January 01, 2021 - The WG also recommended the following “should Have,” second-tier consideration, which MITRE has
also
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2022.pdf
January 01, 2022 - This work is under consideration with AHRQ to continue with any future CDS Connect
projects.
4.2 Simplified … Patient-Facing CDS
Intervention
No Yes Yes Yes
4 Occupational Factors Impacting Diabetes is under consideration … The WG has engaged throughout key
project phases, from consideration of high-level desired outcomes … • Tracking stakeholder recommendations for consideration in future sprints.
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2020.pdf
January 01, 2020 - The team’s criteria for considering updates included consideration of
relevant research evidence, metadata … Baseline 10-
Year ASCVD Risk
No Yes Yes No
10 Occupational Factors Impacting Diabetes is under consideration … The WG has engaged throughout key
project phases, from consideration of high-level desired outcomes … sustainer organizations, Federal partners, and grantees)
• Tracking stakeholder recommendations for consideration
-
cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
November 11, 2019 - are often simplistic in nature or do not take the specific patient and pharmacological contexts into consideration